Study summary
Fifteen years on, about 4 in 10 people with advanced follicular lymphoma may have been cured
42%estimated cure rate
What was tested
Long-term follow-up of a US trial comparing R-CHOP with CHOP plus radioimmunotherapy as first treatment for advanced follicular lymphoma, with statistical cure modeling.
What they found
- 15-year survival was 70% and 15-year progression-free survival 40%.
- Cure modeling estimated 42% were cured, highest in people with low-risk scores.
- Relapse risk fell from 6.8% a year in the first 5 years to 0.6% after 15 years.
What it means
Challenges the long-held view that follicular lymphoma is never curable, and changes the first conversation doctors have with patients.
Last reviewed 2026-11-15 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.